Assessing the Ethics of Medical Research in Emergency Settings: How Do International Regulations Work in Practice?
- Ritva Halila
- … show all 1 hide
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Different ethical principles conflict in research conducted in emergency research. Clinical care and its development should be based on research. Patients in critical clinical condition are in the greatest need of better medicines. The critical condition of the patient and the absence of a patient representative at the critical time period make it difficult and sometimes impossible to request an informed consent before the beginning of the trial. In an emergency, care decisions must be made in a short period of time, and the more time is wasted, the more the risk of death or severe tissue damage and incapacity increases. Consent requests take time, and so the time period before treatment might put the patient’s life in jeopardy. Not requesting consent before a trial is also contradictory. A person should not be forced to participate in a trial against his or her will. Due to the dark history of medical research previously, international declarations and conventions have set up ethical principles for medical research. They emphasize the autonomy of the research participant—or his or her legal representative—to give a free and informed consent prior to the initiation of research. In the case of a critical emergency, the unconscious state of the patient, the emotional stress of family members or the lack of time to start life-sustaining measures may often restrict the possibilities of communicating with the patient or his/her representative. Therefore, written informed consent is difficult to achieve, and its voluntariness in emergency situations is, at best, open to question. The mortality of patients is high without clinical interventions in emergency research. Random selection of patients is difficult and requires extra work from personnel in the emergency rooms. Recruitment, information and asking for consent may also take time, postpone the initiation of treatment and increase the risk of death and irreversible tissue and organ damage, and therefore be risky for the patient. It is therefore essential that the health care professionals recruiting suitable research participants are well motivated and well trained. Medical research in an emergency setting should always be regarded as an exceptional situation requiring special provisions. Only such research should be done as cannot be done in other conditions. An independent body must approve the research protocol and the ways in which the consent of the participant or proxy are to be sought. In addition, the trial must be expected to result in direct and significant benefit for the research participants. If research without prior consent is not approved, the development of emergency care is threatened. On the other hand, if prior consent is not required, a person could be recruited into a clinical trial against his or her will. Doing good and avoiding harm, and respecting the autonomy of the patient are in conflict in the context of emergency medical research. To develop better medicines for patients experiencing acute medical emergencies, research into such conditions should be allowed. Research participants should have the possibility to participate or refuse to participate in research that may benefit them and other patients. The risk of irreversible damage occurring as the consequence of time delays for seeking consent is unacceptable. A prior wish about participation in clinical trials should be respected, if known. The conditions under which medical research in emergencies can be considered acceptable can be determined and agreed upon nationally and internationally.
- The Nuremberg Code: http://ohsr.od.nih.gov/guidelines/nuremberg.html
- World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. At: http://www.wma.net/e/policy/b3.htm
- International Ethical Guidelines for Biomedical Research Involving Human Subjects: At: http://www.cioms.ch/frame_guidelines_nov_2002.htm
- Universal Declaration of Bioethics and Human Rights: At: http://unesdoc.unesco.org/images/0014/001461/146180e.pdf
- Convention for the Protection of Human Rights and Dignity of the Human Being with Regard to the Application of Biology And Medicine: Convention on Human Rights And Biomedicine (ETS 164): In: http://conventions.coe.int http://conventions.coe.int/
- Additional Protocol to the Convention on Human Rights and Biomedicine, concerning Biomedical Research (ETS 195) In: http://conventions.coe.int
- Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use. At: http://ec.europa.eu/enterprise/pharmaceuticals/eudralex/homev1.htm
- Trials of War Criminals before the Nuremberg Military Tribunals under Control Council Law No. 10, Vol. 2, pp. 181–182. Washington, DC: US Government Printing Office, 1949.
- Lov om ændring af lov om et videnskabsetisk komitésystem og behandling af biomedicinske forskningsprojekter (LOV nr 402). (Videre adgang til udførelse af kliniske forsøg med lægemidler på inhabile forsøgspersoner m.v.) LOV nr 272 af 01/04/2006 (Denmark).
- Better medicines to children. Proposed regulatory actions of Paediatric medicinal products. Consultation document. At: http://pharmacos.eudra.org/F2/pharmacos/docs/Doc2002/feb/cd_pediatrics_en.pdf#search=%22better%20medicines%20children%22
- Amended proposal for a regulation of the European Parliament and of the Council on medicinal products for paediatric use and amending Regulation (EEC) No 1768/92, Directive 2001/83/EC and Regulation (EC) No 726/2004. COM (2005) 577 final, 2004/0217 (COD). At: http://ec.europa.eu/enterprise/pharmaceuticals/paediatrics/docs/com_2005_0577_en.pdf
- Communication from the Commission to the European Parliament pursuant to the second subparagraph of Article 251 (2) of the EC Treaty concerning the common position of the Council with a view to the adoption of a regulation on medicinal products for paediatric use and amending Regulation (EEC) No 1768/92, Directive 2001/20/EC, Directive 2001/83/EC and Regulation (EC) No 726/2004. At: http://ec.europa.eu/enterprise/pharmaceuticals/paediatrics/docs/com_2006_118_en.pdf
- Best Pharmaceuticals for Children Act, January 4, 2002 (Public Law No. 107–109).
- See more information at: http://www.fda.gov/cder/pediatric/
- Assessing the Ethics of Medical Research in Emergency Settings: How Do International Regulations Work in Practice?
Science and Engineering Ethics
Volume 13, Issue 3 , pp 305-313
- Cover Date
- Print ISSN
- Online ISSN
- Springer Netherlands
- Additional Links
- Clinical trials
- Emergency medicine
- International declarations
- Ritva Halila (1)
- Author Affiliations
- 1. National Advisory Board on Health Care Ethics, Ministry of Social Affairs and Health, P.O. Box 33, 00023 Government, Helsinki, Finland